Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE unmoved on Takeda bone cancer drug

October 13, 2010
Sales and Marketing Mepact, NICE, Takeda

NICE has refused to recommend Takeda’s Mepact because of its “exceptionally high cost” and the “substantial uncertainty” about the osteosarcoma …

News

Philip Vickers joins Shire

October 13, 2010
Research and Development Shire, appointment, research and development

Shire has appointed Philip Vickers as senior VP of research and development for its Human Genetic Therapies (HGT) business. He …

Appointment
Blog footer

Digital Pharma: Genzyme’s augmented reality heart

October 12, 2010
Medical Communications Digital Pharma blog, Genzyme, augmented reality

Genzyme Europe has launched a new website that allows users to take a peak inside their own heart, or so …

News

Pharmsynthez boosts board

October 12, 2010
Manufacturing and Production, Research and Development Pharmsynthez, appointment, manufacturing and production, research and development

Moscow-based pharmaceutical company JSC Pharmsynthez has appointed Miroslav Ravic and Howard Fisher to its board as independent non-executive directors. Miroslav …

Appointment

UCB signs Parkinson’s research deal

October 12, 2010
Research and Development Parkinson's, Synosia Therapeutics, UCB, neurology

UCB has partnered with Synosia Therapeutics to develop two of the Swiss firm’s compounds for Parkinson’s disease.  Basel-based Synosia has …

News

Stem cell trial re-starts

October 12, 2010
Research and Development Geron, Stem cells, spinal injury

Geron Corporation has enrolled the first patient in its restarted clinical trial of human embryonic stem cells (hESC). The world’s …

News

Making the most of outsourcing and offshoring

October 12, 2010
Manufacturing and Production, Research and Development Kinapse, outsourcing

As the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …

Feature

Merck will appeal EMA’s Movectro decision

October 12, 2010
Sales and Marketing CHMP, EMA, Merck KGaA, Merck Serono, Movectro

Merck KGaA is poised to appeal the EMA’s decision on its MS treatment Movectro after the regulator rejected the drug …

News

UniversalProcon expands UK team

October 11, 2010
Sales and Marketing UniversalProcon, appointment, sales and marketing

Transatlantic event management company UniversalProcon has expanded its UK operations with five new appointments. Sophie Limbert (pictured) joins as a …

Appointment

ABPI’s Barker to step down

October 11, 2010
Sales and Marketing ABPI, appointment, sales and marketing

ABPI director general Dr Richard Barker is to step down in 2011 after six years at the helm of the …

Appointment

Abbott withdraws anti-obesity drug amid safety worries

October 11, 2010
Sales and Marketing Abbott, Meridia, obesity

Abbott has pulled its anti-obesity drug Meridia in the US after recent trials showed it increased the risk of stroke …

News

Treasure trove of cancer information on tap for GPs

October 11, 2010
Medical Communications Cancer, Doctors.net.uk, GP, cancer care, online community, professional network

 Cancer Research UK appoints Doctors.net to launch campaign to raise awareness of the charity’s vast information resources for GPs

News
Press release

Boehringer pulls ‘Pink Viagra’

October 11, 2010
Sales and Marketing Boehringer, Girosa

Boehringer Ingelheim has discontinued development of its hypoactive sexual desire disorder drug Girosa after the FDA refused to approve it. …

News

Sanofi slashes US workforce

October 11, 2010
Sales and Marketing Sanofi-Aventis, job cuts

Sanofi-Aventis is to cut a quarter of its workforce in the US – making 1,700 people redundant – as it …

News

Novartis eyes genomics route for flu vaccines

October 11, 2010
Manufacturing and Production, Research and Development Novartis, Synthetic Genomics Vaccines, genomics

Novartis will make use of a technology developed by Synthetic Genomics Vaccines, a new company set up by genomics pioneer …

News

Fleishman appoints Henry Featherstone

October 8, 2010
Medical Communications Fleishman, appointment, medical communications

Henry Featherstone has joined Fleishman-Hillard’s London healthcare public affairs and corporate communications team as a senior policy adviser. He moves …

Appointment
Blog footer

Digital Pharma: Facebook first from Janssen

October 8, 2010
Medical Communications Digital Pharma blog, Facebook, Janssen, Twitter, ipad, iphone, youtube

Janssen UK has officially launched its new psoriasis disease awareness campaign, part of which includes the first pharma Facebook page …

News

NHS reforms moving ‘too fast’

October 8, 2010
NHS, government, king's fund

The government’s plans to reform the NHS are moving too far according to health think tank the King’s Fund. Radical …

News

Novo Nordisk invests $73m to boost diabetes drug production

October 8, 2010
Manufacturing and Production Novo Nordisk, diabetes, insulin

Novo Nordisk has announced another major expansion of its manufacturing capacity for diabetes products, setting aside $73 million to expand …

News

AZ plans heart attack study for Brilique

October 8, 2010
Research and Development, Sales and Marketing AstraZeneca, Brilinta, Brilique

AstraZeneca is due to begin enrolling patients into a new study of its oral antiplatelet Brilique (ticagrelor) before the end …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026